Optimizing the Tobacco Cessation Clinical Decision Support Tool.
Using Rapid Cycle Randomized Controlled Trials to Study a Tobacco Cessation Best Practice Advisory.
1 other identifier
observational
54,417
1 country
1
Brief Summary
The existing tobacco cessation best practice advisory (BPA) fires for providers (physicians, residents, fellows, midwives, nurse practitioners, physician assistants) during outpatient encounters when a patient is identified as a current tobacco user in the Social History section of their chart. The BPA was designed to help facilitate tobacco cessation interventions; it is part of the The Centers for Medicare \& Medicaid Services (CMS) Quality Payment Program (QPP). The purpose of the project is to optimize this BPA utilization and improve patient outcomes by comparing multiple versions of the tobacco cessation BPA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 3, 2018
CompletedFirst Submitted
Initial submission to the registry
October 4, 2018
CompletedFirst Posted
Study publicly available on registry
October 22, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 24, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 29, 2020
CompletedJuly 21, 2021
July 1, 2021
8 months
October 4, 2018
July 14, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Alert acceptance rate
1 year
Study Arms (3)
Improved outcomes
Regulatory reminder
Billing and documentation
Interventions
The intervention includes different versions of the BPA design and message.
The intervention includes different versions of the BPA design and message.
The intervention includes different versions of the BPA design and message.
Eligibility Criteria
All providers of patients at NYU Langone Health (including NYU Winthrop) who are identified as currents smokers, as documented in the social history of their patient chart, and are eligible to receive the best practice advisory for tobacco cessation.
You may qualify if:
- All providers of patients at NYU Langone Health (including NYU Winthrop) who are identified as currents smokers, as documented in the social history of their patient chart, and are eligible to receive the best practice advisory for tobacco cessation.
You may not qualify if:
- non smokers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York University School of Medicine
New York, New York, 10016, United States
Related Publications (1)
Austrian J, Mendoza F, Szerencsy A, Fenelon L, Horwitz LI, Jones S, Kuznetsova M, Mann DM. Applying A/B Testing to Clinical Decision Support: Rapid Randomized Controlled Trials. J Med Internet Res. 2021 Apr 9;23(4):e16651. doi: 10.2196/16651.
PMID: 33835035DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 4, 2018
First Posted
October 22, 2018
Study Start
October 3, 2018
Primary Completion
May 24, 2019
Study Completion
February 29, 2020
Last Updated
July 21, 2021
Record last verified: 2021-07